Sirolimus in Patients With Systemic Lupus Erythematosus-Associated Immune Thrombocytopenia | MicrobiomeTrials← Back to trialsNCT07657793
Sirolimus in Patients With Systemic Lupus Erythematosus-Associated Immune Thrombocytopenia
RecruitingPHASE2, PHASE3INTERVENTIONAL
Trial Details
Start: 2026-06-07Est. Completion: 2027-09-30
Enrollment target: 164 participants Locations- Peking Union Medical College Hospital, Beijing, Beijing Municipality, China
Other microbiome trials you might be interested in
Autoimmune Diseases
Background:
Autoimmune diseases can be caused by genes people inherit from their parents. The gene changes that cause t…
Bethesda, United StatesEst. completion Apr 22, 2030
Systemic Lupus Erythematosus (Sle)Primary Ovarian Insufficiency (Poi)
Background:
Systemic lupus erythematosus (SLE) is a disease that affects females nine times more often than males. Peop…
Bethesda, United StatesEst. completion May 31, 2027